CD8A and breast carcinoma: In a xenograft mouse model of colon carcinoma and mammary carcinoma, a reduced frequency of PD1 + CD8+ T-cells and a decrease in PD1 levels below a certain threshold were associated with release from adaptive immune resistance [21].